Company Overview of PLx Pharma Inc.
PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing oral drugs for cardiovascular disease, as well as pain and inflammation for the prescription and over-the-counter markets in the United States. The company’s products include PL2200 Aspirin 325 mg, a novel formulation of aspirin that uses the PLxGuard delivery system to reduce acute GI side effects while providing antiplatelet effectiveness for cardiovascular disease prevention; and PL2200 Aspirin 81 mg that is in late-stage development. PLx Pharma Inc. was founded in 2002 and is headquartered in Houston, Texas.
8285 El Rio
Houston, TX 77054
Founded in 2002
Key Executives for PLx Pharma Inc.
PLx Pharma Inc. Key Developments
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
February 23, 2016
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact PLx Pharma Inc., please visit www.plxpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.